Gain of function of immunoglobulins after partial unfolding or cofactor binding

Molecular Immunology

Volumn 55, Issue 3-4, 2013, Pages 195-196

  Dimitrov, Jordan D ^a,b,c   Kaveri, Srinivas V ^a,b,c   Lacroix Desmazes, Sebastien ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; REACTIVE OXYGEN METABOLITE;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; BINDING SITE; ENVIRONMENTAL CHANGE; INTRACELLULAR SIGNALING; LETTER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN UNFOLDING;

DNA-BINDING PROTEINS; MOLECULAR CHAPERONES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84877603553     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.03.009     Document Type: Letter

References (14)

1. Korzhnev D.M. Loss of structure-gain of function. J. Mol. Biol 2013, 425:17-18.
2. Ducett J.K., Peterson F.C., Hoover L.A., Prunuske A.J., Volkman B.F., Craig E.A. Unfolding of the C-terminal domain of the j-protein zuo1 releases autoinhibition and activates pdr1-dependent transcription. J. Mol. Biol. 2013, 425:19-31.
3. Neuberger M.S. Antibody diversification by somatic mutation: from Burnet onwards. Immunol. Cell. Biol. 2008, 86:124-132.
4. Pauling L., Campbell D.H. The Manufacture of Antibodies in Vitro. J. Exp. Med. 1942, 76:211-220.
5. Cabiedes J., Cabral A.R., Alarcon-Segovia D. Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments. Eur. J. Immunol. 1998, 28:2108-2114.
6. McMahon M.J., O'Kennedy R. Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH. J. Immunol. Methods 2000, 241:1-10.
7. Bouvet J.P., Stahl D., Rose S., Quan C.P., Kazatchkine M.D., Kaveri S.V. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J. Autoimmun. 2001, 16:163-172.
8. Dimitrov J.D., Ivanovska N.D., Lacroix-Desmazes S., Doltchinkova V.R., Kaveri S.V., Vassilev T.L. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J. Biol. Chem. 2006, 281:439-446.
9. Dimitrov J.D., Lacroix-Desmazes S., Kaveri S.V., Vassilev T.L. Transition towards antigen-binding promiscuity of a monospecific antibody. Mol. Immunol. 2007, 44:1854-1863.
10. Dimitrov J.D., Pashov A.D., Vassilev T.L. Antibody polyspecificity: what does it matter?. Adv. Exp. Med. Biol. 2012, 750:213-226.
11. McIntyre J.A., Wagenknecht D.R., Faulk W.P. Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun. Rev. 2006, 5:76-83.
12. Dimitrov J.D., Roumenina L.T., Doltchinkova V.R., Mihaylova N.M., Lacroix-Desmazes S., Kaveri S.V., Vassilev T.L. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J. Biol. Chem. 2007, 282:26696-26706.
13. Djoumerska-Alexieva I.K., Dimitrov J.D., Voynova E.N., Lacroix-Desmazes S., Kaveri S.V., Vassilev T.L. Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis. FEBS J. 2010, 277:3039-3050.
14. Mihaylova N.M., Dimitrov J.D., Djoumerska-Alexieva I.K., Vassilev T.L. Inflammation-induced enhancement of IgG immunoreactivity. Inflamm. Res. 2008, 57:1-3.